NCT02831179 2017-09-28Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorVanderbilt-Ingram Cancer CenterPhase 1 Withdrawn
NCT00002947 2014-07-02Indium In 111 Pentetreotide in Treating Patients With Refractory CancerYale UniversityPhase 1 Terminated35 enrolled
NCT00006368 2013-05-01Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNovartisPhase 1 Completed60 enrolled
NCT00004074 2013-02-28Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuNational Cancer Institute (NCI)Phase 1 Completed15 enrolled
NCT00005842 2013-02-11Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNational Cancer Institute (NCI)Phase 1 Completed24 enrolled
NCT00005860 2011-04-26Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumNational Cancer Institute (NCI)Phase 1 Completed